ICL Surgery (Implantable Collamer Lens): Complete Guide
Understanding ICL Surgery
ICL surgery, also known as implantable collamer lens surgery, is a vision correction procedure that places a specially designed biocompatible lens inside the eye to treat nearsightedness and astigmatism. Unlike laser procedures that permanently reshape the cornea, ICL works with your eye's natural anatomy to deliver clear, sharp vision. The lens is made of collamer, a unique material that combines purified collagen with a polymer to create a lens that is highly compatible with the body's natural chemistry. According to a literature review in the Journal of Refractive Surgery covering 95 studies, 92.6 percent of LASIK patients reported being satisfied with their surgery, and ICL satisfaction rates are similarly high (Susanna et al., 2025). At Fairfield County Laser Vision, our refractive surgeon helps patients throughout the greater NY/CT region determine whether ICL is the right path to visual freedom.
While LASIK and other laser procedures correct vision by permanently reshaping the cornea, ICL takes a fundamentally different approach. The ICL is an additive procedure, meaning it places a corrective lens inside the eye without removing or altering any tissue. This distinction has important implications for candidacy, recovery, and long-term flexibility. Because the cornea remains untouched, ICL does not contribute to dry eye the way corneal procedures can, and the lens can be removed or exchanged if a patient's needs change over time.
ICL technology has advanced significantly since its introduction. The EVO ICL, the latest generation of implantable collamer lenses, features a central port called the KS Aquaport that allows natural fluid circulation within the eye. This design improvement eliminated the need for the peripheral iridotomies that were required with earlier ICL models. Modern ICLs also include built-in UV protection and are available in toric versions to correct astigmatism along with nearsightedness.
Who Is a Good Candidate for ICL Surgery
ICL is primarily designed for patients with moderate to severe myopia, typically ranging from about -3.00 to -20.00 diopters. This extended range makes ICL an excellent option for patients whose prescriptions exceed the safe treatment limits of laser vision correction. Candidates should generally be between 21 and 45 years of age with a stable prescription that has not changed significantly in the past year. Patients with mild to moderate astigmatism may also benefit from toric ICL models, which can correct up to 4 diopters of cylinder.
Successful ICL placement requires adequate anterior chamber depth, which is the space between the cornea and the natural lens. This measurement must be at least 2.8 millimeters to safely accommodate the implant. Our refractive surgeon also evaluates endothelial cell density, the health of the cells lining the inner cornea, to confirm that the eye can safely accommodate the lens long-term. Patients with active eye infections, uncontrolled glaucoma, cataracts, or keratoconus are generally not candidates for ICL.
Patients with thin or irregular corneas that make LASIK or PRK risky are often strong candidates for ICL. The procedure is also preferred for patients who experience chronic dry eye, since the corneal nerves are not disrupted during surgery. Athletes and individuals in professions with a risk of eye trauma may appreciate that ICL involves no corneal flap. Additionally, patients who value the reversibility of their vision correction often choose ICL for the peace of mind it provides.
How the ICL Procedure Is Performed
Before surgery, our refractive surgeon performs a comprehensive evaluation that includes measuring anterior chamber depth, corneal topography, endothelial cell count, pupil size, and detailed refraction. These measurements determine the correct ICL size and power for your eyes. The lens is custom-ordered based on your specific measurements, which may take one to two weeks. You will receive instructions about discontinuing contact lenses before your measurements and surgery, as contacts can temporarily alter the shape of your cornea.
On the day of surgery, numbing eye drops are applied to ensure your comfort throughout the procedure. The surgeon creates a small, self-sealing incision of approximately 3 millimeters at the edge of the cornea. The ICL, which is folded for insertion, is gently placed through this incision using a specialized injector. Once inside the eye, the lens unfolds and is positioned behind the iris and in front of the natural crystalline lens. The surgeon confirms proper positioning and centration before completing the procedure. The entire process typically takes about 15 to 20 minutes per eye, and both eyes can often be treated on the same day or within a few days of each other.
Most patients notice a significant improvement in vision almost immediately after surgery. You will rest briefly in the recovery area and then be examined to confirm the lens is properly positioned and that eye pressure is normal. A follow-up visit is typically scheduled for the next day and then at one week, one month, and three months after surgery. You will be given medicated eye drops to prevent infection and control inflammation during the healing period. Plan to have someone drive you home after your procedure.
Advantages of ICL Surgery
Because ICL is placed inside the eye without altering the cornea's shape or removing any tissue, the structural integrity of the cornea is fully preserved. This is particularly valuable for patients with thinner corneas or those who want to avoid permanent changes to the corneal surface. The untouched cornea also means that future laser vision correction remains an option if needed for fine-tuning.
ICL lenses are known for delivering high-definition visual quality, especially in patients with high myopia. The collamer material produces minimal higher-order aberrations, which are subtle optical imperfections that can affect contrast sensitivity and night vision. Many ICL patients report that their vision quality exceeds what they experienced with glasses or contact lenses.
ICL surgery avoids disrupting corneal nerves, which play an important role in tear production and corneal sensation. This is a significant advantage for patients who already have dry eye or who are concerned about developing dry eye after surgery. While some temporary dryness may occur, it is typically much less pronounced than with corneal laser procedures.
Unlike LASIK, which permanently changes the cornea, ICL can be removed or exchanged if your vision needs change. If you develop a cataract later in life, the ICL can be removed at the time of cataract surgery. If your prescription changes significantly, the lens can be exchanged for one with different power. This flexibility provides peace of mind for patients who want a vision correction option that does not close any doors.
Frequently Asked Questions
Yes. ICL is approved to treat myopia ranging from approximately -3.00 to -20.00 diopters, which extends well beyond the safe treatment range for most laser procedures. Patients with prescriptions above -10 or -12 diopters often find that ICL provides better visual quality than high-correction laser treatment because it avoids the corneal changes associated with removing large amounts of tissue.
Most patients experience noticeably clearer vision within the first day after surgery, and many return to work within one to two days. Full visual stabilization typically occurs within one to two weeks. During recovery, you should avoid rubbing your eyes, swimming, and strenuous physical activity as outlined by your surgeon. You will use prescription eye drops for several weeks to support healing.
Yes, one of the unique advantages of ICL is that the lens can be removed or replaced at any time. The removal procedure is straightforward and does not affect the eye's natural structures. This reversibility makes ICL an attractive option for patients who want flexibility in their vision correction choices.
As with any surgical procedure, ICL carries some risks. The most commonly discussed concern is a small increase in the likelihood of cataract formation, though modern sizing techniques and the EVO ICL's central port design have significantly reduced this risk. Other potential complications include elevated intraocular pressure, infection, and the rare need for lens repositioning. Our refractive surgeon discusses all risks during your consultation.
An ICL is designed to remain in the eye permanently. The collamer material is biocompatible and does not degrade over time. However, ICL does not prevent age-related changes such as presbyopia or cataracts, which may require additional treatment in the future.
ICL adds a lens while preserving your natural lens, making it ideal for younger patients who still have good focusing ability. Refractive lens exchange replaces your natural lens entirely and is typically recommended for patients over 50 who may be developing early cataracts. Our refractive surgeon can help determine which approach is best for your age and visual needs.
What our Patients say
4.8
Reviews
(3547)